Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Awad

Showing results (681-690 of 839) with videos related to

Pageof 84
Sort By:
Transplantation Proceedings|February 22, 2017
Combined Heart and Kidney Transplantation: A 23-Year ExperienceM Awad, L S C Czer, F Esmailian, et al.
Cancer Discovery|October 4, 2016
Acquired METD1228V Mutation and Resistance to MET Inhibition in Lung CancerMagda Bahcall, Taebo Sim, Cloud P Paweletz, et al.
Chemical Research in Toxicology|September 21, 2004
Human cytochrome p450 enzyme specificity for bioactivation of safrole to the proximate carcinogen 1'-hydroxysafroleSuzanne M F Jeurissen, Jan J P Bogaards, Hanem M Awad, et al.
ESMO Open|September 9, 2022
Phase Ib study of eprenetapopt (APR-246) in combination with pembrolizumab in patients with advanced or metastatic solid tumorsH Park, G I Shapiro, X Gao, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 12, 2021
SMARCA4 and Other SWItch/Sucrose NonFermentable Family Genomic Alterations in NSCLC: Clinicopathologic Characteristics and Outcomes to Immune Checkpoint InhibitionJoao V Alessi, Biagio Ricciuti, Liam F Spurr, et al.
BMC Geriatrics|November 22, 2025
Ultrasonographic changes in median nerve cross-sectional area in the elderly: effects of aging and type 2 diabetesMohamed A Bedewi, Ezzat M Awad, Mamdouh Ali Kotb, et al.
Cancer|September 9, 2025
Real-world outcomes of neoadjuvant chemoimmunotherapy in patients with nonsmall cell lung cancer: Predictors of surgery, pathologic complete response, and event-free survivalAlissa J Cooper, Edoardo Garbo, Andrea Arfe, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 16, 2021
Predictors of Rheumatic Immune-Related Adverse Events and De Novo Inflammatory Arthritis After Immune Checkpoint Inhibitor Treatment for CancerAmy Cunningham-Bussel, Jiaqi Wang, Lauren C Prisco, et al.
The Lancet. Oncology|May 11, 2020
Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label, multicentre, single-arm, phase 2 trialCatherine A Shu, Justin F Gainor, Mark M Awad, et al.
American Journal of Respiratory and Critical Care Medicine|October 13, 2000
Gene delivery to the corneal endotheliumA J George, C V Arancibia-Cárcamo, H M Awad, et al.
Pageof 84

Showing results (681-690 of 839) with videos related to

Sort By:
Pageof 84
Transplantation Proceedings|February 22, 2017
Combined Heart and Kidney Transplantation: A 23-Year ExperienceM Awad, L S C Czer, F Esmailian, et al.
Cancer Discovery|October 4, 2016
Acquired METD1228V Mutation and Resistance to MET Inhibition in Lung CancerMagda Bahcall, Taebo Sim, Cloud P Paweletz, et al.
Chemical Research in Toxicology|September 21, 2004
Human cytochrome p450 enzyme specificity for bioactivation of safrole to the proximate carcinogen 1'-hydroxysafroleSuzanne M F Jeurissen, Jan J P Bogaards, Hanem M Awad, et al.
ESMO Open|September 9, 2022
Phase Ib study of eprenetapopt (APR-246) in combination with pembrolizumab in patients with advanced or metastatic solid tumorsH Park, G I Shapiro, X Gao, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 12, 2021
SMARCA4 and Other SWItch/Sucrose NonFermentable Family Genomic Alterations in NSCLC: Clinicopathologic Characteristics and Outcomes to Immune Checkpoint InhibitionJoao V Alessi, Biagio Ricciuti, Liam F Spurr, et al.
BMC Geriatrics|November 22, 2025
Ultrasonographic changes in median nerve cross-sectional area in the elderly: effects of aging and type 2 diabetesMohamed A Bedewi, Ezzat M Awad, Mamdouh Ali Kotb, et al.
Cancer|September 9, 2025
Real-world outcomes of neoadjuvant chemoimmunotherapy in patients with nonsmall cell lung cancer: Predictors of surgery, pathologic complete response, and event-free survivalAlissa J Cooper, Edoardo Garbo, Andrea Arfe, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 16, 2021
Predictors of Rheumatic Immune-Related Adverse Events and De Novo Inflammatory Arthritis After Immune Checkpoint Inhibitor Treatment for CancerAmy Cunningham-Bussel, Jiaqi Wang, Lauren C Prisco, et al.
The Lancet. Oncology|May 11, 2020
Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label, multicentre, single-arm, phase 2 trialCatherine A Shu, Justin F Gainor, Mark M Awad, et al.
American Journal of Respiratory and Critical Care Medicine|October 13, 2000
Gene delivery to the corneal endotheliumA J George, C V Arancibia-Cárcamo, H M Awad, et al.
Pageof 84